3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Sexual Dysfunction, Physiological
1
Non-Small Cell Lung Cancer ALK-positive
1
Neuroblastoma
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Lung Diseases
1
Hyperlipidemias
1
Eunuchism
1
Erectile Dysfunction
1
Brain Neoplasms
1
ALK-positive Non-small Cell Lung Cancer
1
ALK-positive NSCLC
1
Interventions
Bronchoscopy
2
Blood Specimen Collection
2
lorlatinib
1
Vital Signs
1
Radiomics
1
Patient Reported Outcome Measures
1
Magnetic Resonance Spectroscopy
1
Drug Delivery Systems
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lung Diseases
×
lorlatinib
×
Clear all
NCT05167500
2023-03-30
LORLAPULM
Fundación GECP
Completed
118 enrolled